Targeting phosphodiesterase-5 by vardenafil improves vascular graft function
Ischaemia reperfusion (IR) injury occurs during vascular graft harvesting and implantation during vascular/cardiac surgery. Elevated intracellular cyclic guanosine monophosphate (cGMP) levels contribute to an effective endothelial protection in different pathophysiological conditions. The hypothesis...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 2018
|
| In: |
European journal of vascular and endovascular surgery
Year: 2018, Volume: 56, Issue: 2, Pages: 256-263 |
| ISSN: | 1532-2165 |
| DOI: | 10.1016/j.ejvs.2018.03.025 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejvs.2018.03.025 Verlag, lizenzpflichtig, Volltext: https://www.ejves.com/article/S1078-5884(18)30166-7/abstract |
| Author Notes: | Gábor Veres, Meike Hagenhoff, Harald Schmidt, Tamás Radovits, Sivakkanan Loganathan, Yang Bai, Sevil Korkmaz-Icöz, Paige Brlecic, Alex Ali Sayour, Matthias Karck, Gábor Szabó |
| Summary: | Ischaemia reperfusion (IR) injury occurs during vascular graft harvesting and implantation during vascular/cardiac surgery. Elevated intracellular cyclic guanosine monophosphate (cGMP) levels contribute to an effective endothelial protection in different pathophysiological conditions. The hypothesis that the phosphodiesterase-5 inhibitor vardenafil would protect vascular grafts against IR injury by upregulating the nitric oxide-cGMP pathway in the vessel wall of the bypass graft was investigated. |
|---|---|
| Item Description: | Gesehen am 09.04.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1532-2165 |
| DOI: | 10.1016/j.ejvs.2018.03.025 |